IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Quality of IOL is predictive of posterior capsule opacification that needed yag laser capsulotomy for correction of quality of vission: a cohort study

Author: DR. YOUSIF
Abstract: Background:In our clinical practice we observe that post operativeopacification is more frequently associated with particular types of lens, in term of manufacturer origin, than others. This observation is shared by a number of authors who raised the issue of artificial lens quality in association with post IOL capsular opacification. However, controversy exists and no consensus can be easily obtained form available published articles with this regard. Aim of the study:we retrospectively collected data about 514 patients who underwent cataract surgery and IOL implantation, with a main objective of linking post IOL opacification, indicated by need for Yag laser capsulotomy, with the quality of artificial lens used, indicated by manufacturer origin. Patients and method:The present retrospective cohort study was carried out at Ibsar Surgery Center in Al- Najaf province, Iraq. The study started on March 2014 and extended through April 2017, lasting for approximately three years.Inclusion criteria was defined as all cases of cataract surgery by phacoemulsification with no intraoperative complications like posterior capsule rupture, no primary posterior capsule thickening or opacification at time of surgery, no history of trauma provided that all cases share the same surgeon and the same phacoemulsification machine (Infiniti Vision system by Alcon, USA), the same energy power setting and the same type of viscoelastic material used. Results:Iq lens was the most frequently use lens, therefore it was regarded as a reference for purpose of comparison. The need for Yag laser according to lens type varied from 0 to 100 %; however, ceratin types of lenses were used very infrequently and rate in % may be magnified. Nevertheless, no significant variation was seen in any type of lens with respect to need of Yaq laser (P> 0.05. The need for Yag laser was no significantly correlated to age, gender and degree of the IOL. Conclusion:Based on our results and previous reports, the type of lens may affect the need to Yag laser to correct post operativeopacification however more research work is needed in order to reach a clear consensus with this regard.
Keyword: Quality of IOL, posterior capsule opacification, Yag laser
DOI: https://doi.org/10.31838/ijpr/2019.11.04.030
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus